Patents by Inventor Irma Bernatchez-Lemaire

Irma Bernatchez-Lemaire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090124555
    Abstract: The invention relates to the use of Histogranin-like compounds to reduce P2X7 (also designed P2Z) receptor function. The invention also provides a method for the prevention and treatment of rheumatoid arthritis and a variety of diseases/disorders including inflammatory disorders and neurodegenerative diseases.
    Type: Application
    Filed: August 23, 2006
    Publication date: May 14, 2009
    Inventors: Irma Bernatchez-Lemaire, Simon Lemaire
  • Patent number: 7183279
    Abstract: The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: February 27, 2007
    Assignee: University of Ottawa
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Publication number: 20060252673
    Abstract: The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Application
    Filed: May 25, 2006
    Publication date: November 9, 2006
    Applicant: University of Ottawa
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Patent number: 7074786
    Abstract: The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: July 11, 2006
    Assignee: University of Ottawa
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Patent number: 6972281
    Abstract: The invention relates to new basic amino acid derivatives of general formula I and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Grant
    Filed: February 7, 2002
    Date of Patent: December 6, 2005
    Assignee: University of Ottawa
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Publication number: 20050233953
    Abstract: The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Application
    Filed: March 14, 2005
    Publication date: October 20, 2005
    Applicant: University of Ottawa
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le
  • Publication number: 20030176329
    Abstract: The invention relates to new basic amino acid derivatives of general formulae I, II and III, and the preparation and use thereof in treatment of pain. The compounds have histogranin-like antinociceptive, morphine potentiating and COX-2 induction modulating activities.
    Type: Application
    Filed: February 7, 2002
    Publication date: September 18, 2003
    Inventors: Simon Lemaire, Irma Bernatchez-Lemaire, Hoang-Thanh Le